EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Identifying diabetogenic drugs using real world health care databases: A Danish and Australian symmetry analysis

Lars Christian Lund iD, Patricia Hjorslev Jensen, Anton Pottegård iD, Morten Andersen iD, Nicole Pratt iD, Jesper Hallas iD

Diabetes, Obesity and Metabolism · 2023

DOI: 10.1111/dom.14982 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diabetes, Obesity and Metabolism, 2023. Verfasst von Lars Christian Lund und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, Odense, Denmark. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Drug‐induced diabetes is underreported in conventional drug safety monitoring and may contribute to the increasing incidence of type 2 diabetes. Therefore, we used routinely collected prescription data to screen all commonly used drugs for diabetogenic effects.

Methods

Leveraging the Danish nationwide health registries, we used a case‐only symmetry analysis design to evaluate all possible associations between drug initiation and subsequent diabetes. The study was conducted among individuals aged ≥40 years with a first‐ever prescription for any antidiabetic drug 1996‐2018 (n = 348 996). Sequence ratios (SRs) and 95% confidence intervals (CIs) were obtained for all possible drug class‐diabetes combinations. A lower bound of the 95% CI >1.00 was considered a signal. Signals generated in Denmark were replicated using the Services Australia, Pharmaceutical Benefits Scheme 10% data extract.

Results

Overall, 386 drug classes were investigated, of which 70 generated a signal. In total, 43 were classified as previously known based on the SIDER database or a literature review, for example, glucocorticoids (SR 1.67, 95% CI 1.62‐1.72) and β‐blockers (SR 1.20, 95% CI 1.16‐1.23). Of 27 new signals, three drug classes yielded a signal in both the Danish and Australian data source: digitalis glycosides (SR 2.15, 95% CI 2.04‐2.27, and SR 1.76, 95% CI 1.50‐2.08), macrolides (SR 1.20, 95% CI 1.16‐1.24, and SR 1.11, 95% CI 1.06‐1.16) and inhaled β2‐agonists combined with glucocorticoids (SR 1.35, 95% CI 1.28‐1.42, and SR 1.14, 95% CI 1.06‐1.22).

Conclusion

We identified 70 drug‐diabetes associations, of which 27 were classified as hitherto unknown. Further studies evaluating the hypotheses generated by this work are needed, particularly for the signal for digitalis glycosides.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2HumansGlucocorticoidsGlobal HealthAustraliaHypoglycemic AgentsDenmark

Stichwörter der Autor:innen

adverse drug reactionsdiabetes mellituspharmacoepidemiology

Substanzen

GlucocorticoidsHypoglycemic Agents

Autor:innen und Institutionen

  • Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, Odense, Denmark.
  • Department of Clinical Pharmacology, Odense University Hospital, Odense, Denmark.
  • Pharmacovigilance Research Center, Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.
  • Quality Use of Medicines and Pharmacy Research Centre, Clinical and Health Sciences, University of South Australia, Adelaide, Australia.

ORCID-Profile: Lars Christian Lund, Anton Pottegård, Morten Andersen, Nicole Pratt, Jesper Hallas

Zitieren

APA

Lund, L. C., Jensen, P. H., Pottegård, A., Andersen, M., Pratt, N., & Hallas, J. (2023). Identifying diabetogenic drugs using real world health care databases: A Danish and Australian symmetry analysis. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.14982

Vancouver

Lund LC, Jensen PH, Pottegård A, Andersen M, Pratt N, Hallas J. Identifying diabetogenic drugs using real world health care databases: A Danish and Australian symmetry analysis. Diabetes, Obesity and Metabolism. 2023. doi:10.1111/dom.14982

BibTeX
@article{Lund2023,
  author = {Lund, Lars Christian and Jensen, Patricia Hjorslev and Pottegård, Anton and Andersen, Morten and Pratt, Nicole and Hallas, Jesper},
  title = {Identifying diabetogenic drugs using real world health care databases: A Danish and Australian symmetry analysis},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2023},
  doi = {10.1111/dom.14982}
}
Kostenlos starten →